Oct 17, 2025
1:125
For every 125 shares held, investors received 1. The price per share adjusted from $0.25 to $31.15.
The split itself did not change the total investment value.
Xbrane Biopharma AB (STO:XBRANE) operates in the Pharmaceuticals: major industry.
Xbrane Biopharma AB company overviewXbrane Biopharma AB's most recent stock split was on October 17, 2025. It was a 1-for-125 reverse split, so shareholders received 1 share for every 125 they held.
Xbrane Biopharma AB (STO:XBRANE) has split its stock 4 times: a 338-for-327 split on March 6, 2019, a 797-for-781 split on June 25, 2019, a 591-for-67 split on February 23, 2024, and a 1-for-125 reverse split on October 17, 2025.
Xbrane Biopharma AB has split its stock 4 times. This history records 4 splits between March 6, 2019 and October 17, 2025.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Xbrane Biopharma AB's 1-for-125 reverse split on October 17, 2025, every 125 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Xbrane Biopharma AB has not announced a new split in our records. Its most recent split was on October 17, 2025, 1 year ago. Companies announce splits in advance, and any new STO:XBRANE split will appear on this page.
Already premium?